Zhejiang Huahai Pharmaceutical Co., Ltd.SSE: 600521

Announcement on Implementation of Dividend Distribution for 2025

Jun 12, 2026 · Issued by Zhejiang Huahai Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jun 12, 2026 · 4 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-implementation-of-dividend-distribution-for-2025-133

Release

Announcement on Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Huahai Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Huahai Pharmaceutical

Announcement on Obtaining Drug Registration CertificateJun 9
Indicative Announcement on Suspending Conversion of "Huahai Convertible Bonds" When Implementing Dividend Distribution for 2025Jun 6
Announcement on Release of Pledge and Re-pledge of Some Shares of ShareholdersJun 5
Announcement on Obtaining Approval for Drug Clinical Trials by SubsidiaryJun 3
Announcement on Convening Performance Briefing for 2025 and Q1 2026May 27

Later from Zhejiang Huahai Pharmaceutical

Announcement on Progress in Transfer of Equity in Subsidiary Huahai Tianheng (Shanghai) Pharmaceutical Research Co., Ltd.Jun 13
Announcement on Obtaining Drug Registration Certificate by the Company and Its SubsidiariesJun 16
Announcement on Progress in Arbitration Case Involving the CompanyJun 24
Indicative Announcement on Acceptance of the Subsidiary’s Application for Marketing Authorization of DrugsJun 26
Announcement on Resolutions of the 13th Extraordinary Meeting of the 9th Board of DirectorsJun 27

All Zhejiang Huahai Pharmaceutical news releases

Follow Zhejiang Huahai Pharmaceutical into a list and get an email when it puts out news.

Follow Zhejiang Huahai Pharmaceutical